Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Use of a trigger tool to detect adverse drug reactions in an emergency department.

de Almeida SM, Romualdo A, de Abreu Ferraresi A, Zelezoglo GR, Marra AR, Edmond MB.

BMC Pharmacol Toxicol. 2017 Nov 15;18(1):71. doi: 10.1186/s40360-017-0177-y.

2.

Outcome after Discontinuation of Proton Pump Inhibitors at a Residential Care Site: Quality Improvement Project.

Lee C, Lo A, Ubhi K, Milewski M.

Can J Hosp Pharm. 2017 May-Jun;70(3):215-223. Epub 2017 Jun 30.

3.

Adverse Drug Events in Patients with Mental Disorder in an Ambulatory Setting.

Kumar N, Sharma S, Kapoor V.

Int J Appl Basic Med Res. 2017 Apr-Jun;7(2):108-111. doi: 10.4103/2229-516X.205822.

4.

Emergency department visits involving benzodiazepines and non-benzodiazepine receptor agonists.

Kaufmann CN, Spira AP, Alexander GC, Rutkow L, Mojtabai R.

Am J Emerg Med. 2017 Oct;35(10):1414-1419. doi: 10.1016/j.ajem.2017.04.023. Epub 2017 Apr 14.

PMID:
28476551
5.

Examining the relationship between therapeutic self-care and adverse events for home care clients in Ontario, Canada: a retrospective cohort study.

Sun W, Doran DM, Wodchis WP, Peter E.

BMC Health Serv Res. 2017 Mar 14;17(1):206. doi: 10.1186/s12913-017-2103-9.

6.

Evaluation of Potentially Drug-Related Patient-Reported Common Symptoms Assessed During Clinical Medication Reviews: A Cross-Sectional Observational Study.

Schoenmakers TW, Teichert M, Wensing M, de Smet PA.

Drug Saf. 2017 May;40(5):419-430. doi: 10.1007/s40264-017-0504-7.

7.

Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms.

Ventura MT, Scichilone N, Paganelli R, Minciullo PL, Patella V, Bonini M, Passalacqua G, Lombardi C, Simioni L, Ridolo E, Del Giacco SR, Gangemi S, Canonica GW.

Clin Mol Allergy. 2017 Feb 3;15:2. doi: 10.1186/s12948-017-0059-2. eCollection 2017. Review.

8.

Prediction of Hospitalization due to Adverse Drug Reactions in Elderly Community-Dwelling Patients (The PADR-EC Score).

Parameswaran Nair N, Chalmers L, Connolly M, Bereznicki BJ, Peterson GM, Curtain C, Castelino RL, Bereznicki LR.

PLoS One. 2016 Oct 31;11(10):e0165757. doi: 10.1371/journal.pone.0165757. eCollection 2016.

9.

Deprescription: The prescription metabolism.

Sivagnanam G.

J Pharmacol Pharmacother. 2016 Jul-Sep;7(3):133-7. doi: 10.4103/0976-500X.189680. Review.

10.

Pilot study to test the feasibility of a trial design and complex intervention on PRIoritising MUltimedication in Multimorbidity in general practices (PRIMUMpilot).

Muth C, Harder S, Uhlmann L, Rochon J, Fullerton B, G├╝thlin C, Erler A, Beyer M, van den Akker M, Perera R, Knottnerus A, Valderas JM, Gerlach FM, Haefeli WE.

BMJ Open. 2016 Jul 25;6(7):e011613. doi: 10.1136/bmjopen-2016-011613.

11.

A comparison of drug therapy problems in patients eligible and ineligible for provincial medication review programs in Canada.

Pammett R, Jorgenson D.

Can Pharm J (Ott). 2016 May;149(3):125-9. doi: 10.1177/1715163516640295. Epub 2016 Mar 29. No abstract available.

12.

Routine deprescribing of chronic medications to combat polypharmacy.

Garfinkel D, Ilhan B, Bahat G.

Ther Adv Drug Saf. 2015 Dec;6(6):212-33. doi: 10.1177/2042098615613984. Review.

13.

Promoting Safe Use of Medications: Providing Medication Education to Seniors Receiving Meals on Wheels.

Ward KE, Cohen LB.

Consult Pharm. 2015 Oct;30(10):616-22. doi: 10.4140/TCP.n.2015.616.

14.
15.

Injury in the aged: Geriatric trauma care at the crossroads.

Kozar RA, Arbabi S, Stein DM, Shackford SR, Barraco RD, Biffl WL, Brasel KJ, Cooper Z, Fakhry SM, Livingston D, Moore F, Luchette F.

J Trauma Acute Care Surg. 2015 Jun;78(6):1197-209. doi: 10.1097/TA.0000000000000656. Review. No abstract available.

16.

Risk factors of self-reported adverse drug events among Medicare enrollees before and after Medicare Part D.

Shiyanbola OO, Farris KB, Urmie JM, Doucette WR.

Pharm Pract (Granada). 2009 Oct;7(4):218-27. Epub 2009 Mar 15.

17.

Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy.

Popa MA, Wallace KJ, Brunello A, Extermann M, Balducci L.

J Geriatr Oncol. 2014 Jul;5(3):307-14. doi: 10.1016/j.jgo.2014.04.002. Epub 2014 May 10.

18.

Applying the 2003 Beers update to elderly Medicare enrollees in the Part D program.

Blackwell SA, Montgomery MA, Baugh DK, Ciborowski GM, Riley GF.

Medicare Medicaid Res Rev. 2012 May 31;2(2). pii: mmrr.002.02.a01. doi: 10.5600/mmrr.002.02.a01. eCollection 2012.

19.

Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update.

Wedemeyer RS, Blume H.

Drug Saf. 2014 Apr;37(4):201-11. doi: 10.1007/s40264-014-0144-0. Review.

20.

Eligibility requirements for community pharmacy medication review services in Canada.

Pammett R, Jorgenson D.

Can Pharm J (Ott). 2014 Jan;147(1):20-4. doi: 10.1177/1715163513514006. No abstract available.

Supplemental Content

Support Center